The Discounted Cash Flow (DCF) valuation of AFT Pharmaceuticals Ltd (AFT.NZ) is 3.46 NZD. With the latest stock price at 2.66 NZD, the upside of AFT Pharmaceuticals Ltd based on DCF is 30.2%.
Based on the latest price of 2.66 NZD and our DCF valuation, AFT Pharmaceuticals Ltd (AFT.NZ) is a buy. buying AFT.NZ stocks now will result in a potential gain of 30.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 9.4% | 7.9% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 2.24 - 7.35 | 3.46 |
| Upside | -16.0% - 176.2% | 30.2% |